These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17434399)
1. Use of high-sensitivity CRP to predict first cardiovascular events. Stahl HD Lancet; 2007 Apr; 369(9569):1259-1260. PubMed ID: 17434399 [No Abstract] [Full Text] [Related]
3. Is hsCRP Back on Board? Implications from the JUPITER Trial. Koenig W Clin Chem; 2009 Feb; 55(2):216-8. PubMed ID: 19074517 [No Abstract] [Full Text] [Related]
9. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older. Ann Intern Med; 2010 Apr; 152(8):I34. PubMed ID: 20404365 [No Abstract] [Full Text] [Related]
10. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. Feeman WE Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687 [No Abstract] [Full Text] [Related]
11. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. Sniderman AD Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690 [No Abstract] [Full Text] [Related]
12. Rosuvastatin in patients with elevated C-reactive protein. Jenny-Avital ER N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275 [No Abstract] [Full Text] [Related]
13. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. Rosenstein R; Parra D Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577689 [No Abstract] [Full Text] [Related]
14. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. Danchin N Lancet; 2009 Jul; 374(9683):24-5; author reply 26-7. PubMed ID: 19577685 [No Abstract] [Full Text] [Related]
15. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439 [No Abstract] [Full Text] [Related]
16. JUPITER, rosuvastatin, and the European Medicines Agency. Ridker PM; Glynn RJ Lancet; 2010 Jun; 375(9731):2071. PubMed ID: 20494436 [No Abstract] [Full Text] [Related]
17. Rosuvastatin in patients with elevated C-reactive protein. Chan PS; Nallamothu BK; Hayward RA N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273 [No Abstract] [Full Text] [Related]
18. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. de Tena JG Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577686 [No Abstract] [Full Text] [Related]
19. Expanding the orbit of primary prevention--moving beyond JUPITER. Hlatky MA N Engl J Med; 2008 Nov; 359(21):2280-2. PubMed ID: 18997195 [No Abstract] [Full Text] [Related]